Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Family Medicine
Acne Clinical Trials
A listing of Acne medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
San Diego : Therapeutics Clinical Research
Study on the safety and effectiveness of a new topical investigational medication for patients with acne.
Santa Rosa : Radiant Research - Santa Rosa
Clinical Research for Acne
View More »
Los Angeles : Dermatology Research Associates
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
San Diego : University Clinical Trials
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
San Diego : Therapeutics Clinical Research
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Florida
Pembroke Pines : University Clinical Research, Inc.
Facial Acne Study for Men or Women Ages 12 to 65. Compensation for time and travel may be up to $200.00
Pinellas Park : Radiant Research - St. Petersburg
Clinical Research Study for Acne
View More »
Orange Park : Site Reference ID/Investigator# 56323
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Sanford : International Clinical Research - US, LLC
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Tampa : Site Reference ID/Investigator# 95826
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Georgia
Snellville : Gwinnett Clinical Research Center, Inc.
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Illinois
Chicago : DeNova Research
Treatment for Acne
View More »
Arlington Heights : Altman Dermatology Associates
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Indiana
Plainfield : Indiana Clinical Trials Center
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Massachusetts
Boston : Site Reference ID/Investigator# 58902
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Michigan
Sterling Heights : Site Reference ID/Investigator# 96095
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Nebraska
Omaha : Site Reference ID/Investigator# 59203
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
New York
New York : Manhattan Medical Research
Do you have facial blemishes due to acne?
North Carolina
Raleigh : Wake Research Associates
Acne Rosaea
Salisbury : PMG Research of Salisbury
Does clear skin seem out of reach? Acne research enrolling for a limited time.
View More »
Chapel Hill : Site Reference ID/Investigator# 56317
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Winston-Salem : Site Reference ID/Investigator# 56316
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Ohio
Pennsylvania
Hershey : Penn State Milton S. Hershey Medical Center - Dept. of Dermatology
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Pittsburgh : Site Reference ID/Investigator# 56305
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Rhode Island
Johnston : Clinical Partners, LLC
Do you have acne?
View More »
Johnston : Clinical Partners, LLC
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
South Carolina
Tennessee
Nashville : Site Reference ID/Investigator# 56306
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Texas
Austin : Premier Research Clinical Research Centers - Austin
Do You Think You Have Rosacea?
Dallas : Research Across America
Facial Acne Research Study
Katy : Research Across America
Facial Acne Research Study
View More »
College Station : J & S Studies
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Houston : UT Houston Health Science Center
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Virginia
Norfolk : Virginia Clinical Research, Inc.
Moderate to Severe Facial Acne
View More »
Norfolk : Virginia Clinical Research
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris
Norfolk : Site Reference ID/Investigator# 48828
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Washington
Seattle : Site Reference ID/Investigator# 102495
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Australia
Benowa : Site Reference ID/Investigator# 68063
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Brisbane : Site Reference ID/Investigator# 65726
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Carlton : Site Reference ID/Investigator# 65727
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Fremantle : Site Reference ID/Investigator# 65729
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Phillip : Site Reference ID/Investigator# 68082
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
View More »
St. Leonards : Site Reference ID/Investigator# 65723
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Brazil
são Paulo : Federal University of São Paulo-Dermatology
The Influence of Peripheral Androgen Conversion at Women Adult Acne
Canada
Barrie : Site Reference ID/Investigator# 61865
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Halifax : Site Reference ID/Investigator# 60686
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Moncton : Site Reference ID/Investigator# 60290
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Montreal : Galderma Investigational site
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients
Surrey : Site Reference ID/Investigator# 60288
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
View More »
Waterloo : Site Reference ID/Investigator# 60687
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Denmark
Aarhus C : Site Reference ID/Investigator# 60088
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Copenhagen NV : Site Reference ID/Investigator# 60090
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Hellerup : Site Reference ID/Investigator# 60089
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Roskilde : Site Reference ID/Investigator# 60091
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Dominican Republic
Santo Domingo : Instituto Dermatologico & Cirugia de Piel
A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne
France
Nantes Cedex 1 : Site Reference ID/Investigator# 60093
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Paris Cedex 10 : Site Reference ID/Investigator# 60092
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Pessac : Site Reference ID/Investigator# 62678
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Poitiers Cedex : Site Reference ID/Investigator# 62680
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Reims Cedex : Site Reference ID/Investigator# 64182
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Greece
Athens : Site Reference ID/Investigator# 60096
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Athens : Site Reference ID/Investigator# 62681
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Haidari, Athens : Site Reference ID/Investigator# 60097
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Heraklion : Site Reference ID/Investigator# 62682
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Thessaloniki : Site Reference ID/Investigator# 62683
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Honduras
San Pedro Sula : Hospital Y Clinica Bendana
A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne
Israel
Tel-Aviv : Sourasky medical center
Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients
Tel-Aviv : Tel-Nordau Clalit health services
Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients
Netherlands
Amsterdam : Site Reference ID/Investigator# 60100
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Rotterdam : Site Reference ID/Investigator# 60101
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Puerto Rico
Carolina : Site Reference ID/Investigator# 58814
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Sweden
Lund : Site Reference ID/Investigator# 62382
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Stockholm : Site Reference ID/Investigator# 67972
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Stockholm : Site Reference ID/Investigator# 60103
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Switzerland
Bern : Site Reference ID/Investigator# 67605
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Geneva 14 : Site Reference ID/Investigator# 69302
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Lausanne : Site Reference ID/Investigator# 67606
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
St. Gallen : Site Reference ID/Investigator# 70253
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
Zurich : Site Reference ID/Investigator# 67603
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
